Voloridge Investment Management
ALBO

Voloridge Investment Management’s Albireo Pharma Inc ALBO Stock Holding History

Voloridge Investment Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,813
Closed -$227K – 1644
2020
Q3 		$227K Buy
+6,813
New +$198K ﹤0.01% 1181

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Voloridge Investment Management's ALBO Position: Q4 2020 in Review

Voloridge Investment Management sold out of Albireo Pharma Inc (ALBO) in Q4 2020, closing a stake of 6,813 shares — an estimated $227K sold.

Voloridge Investment Management first reported a position in ALBO in Q3 2020 and held it in 1 quarter. The position peaked at $227K in Q3 2020. 107 funds tracked by Wall St. Rank hold ALBO as of Q4 2020.

  • Voloridge Investment Management reported no remaining Albireo Pharma Inc position as of Q4 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 6,813 Albireo Pharma Inc shares in Q4 2020, an estimated $227K.
  • Voloridge Investment Management first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 1 quarter.
  • Voloridge Investment Management's Albireo Pharma Inc position peaked at $227K in Q3 2020.
  • 107 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2020.

Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.